US 7419957
Peptides of melanoma antigen and their use in diagnostic, prophylactic and therapeutic methods
granted A61KA61K38/00A61P
Quick answer
US patent 7419957 (Peptides of melanoma antigen and their use in diagnostic, prophylactic and therapeutic methods) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Sep 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K38/00, A61P, A61P35/00, A61P37/02